Warning: The NCBI web site requires JavaScript to function. more...
The economic burden of inpatient paediatric care in Kenya: household and provider costs for treatment of pneumonia, malaria and meningitis.
Ayieko P, Akumu AO, Griffiths UK, English M.
Cost Eff Resour Alloc. 2009 Jan 22;7:3.
Related citations
Costing of severe pneumonia in hospitalized infants and children aged 2-36 months, at a secondary and tertiary level hospital of a not-for-profit organization.
Madsen HO, Hanehøj M, Das AR, Moses PD, Rose W, Puliyel M, Konradsen F, John KR, Bose A.
Trop Med Int Health. 2009 Oct;14(10):1315-22. Epub 2009 Aug 28.
Costs and cost-effectiveness of delivering intermittent preventive treatment through schools in western Kenya.
Temperley M, Mueller DH, Njagi JK, Akhwale W, Clarke SE, Jukes MC, Estambale BB, Brooker S.
Malar J. 2008 Sep 30;7:196.
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL, Figgitt DP.
Pharmacoeconomics. 2004;22(6):389-411. Review.
Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia.
Chola L, Robberstad B.
Cost Eff Resour Alloc. 2009 Oct 21;7:16.
The cost of uncomplicated childhood fevers to Kenyan households: implications for reaching international access targets.
Larson BA, Amin AA, Noor AM, Zurovac D, Snow RW.
BMC Public Health. 2006 Dec 29;6:314.
Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M, Crowther R, Almaraz-Serrano A, Creed F, Sledge W, Kluiter H, Roberts C, Hill E, Wiersma D, Bond GR, Huxley P, Tyrer P.
Health Technol Assess. 2001;5(21):1-75. Review.
Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.
J Manag Care Pharm. 2010 May;16(4):264-75.
Zimbabwe's hospital referral system: does it work?
Sanders D, Kravitz J, Lewin S, McKee M.
Health Policy Plan. 1998 Dec;13(4):359-70.
The economic costs of malaria in four Kenyan districts: do household costs differ by disease endemicity?
Chuma J, Okungu V, Molyneux C.
Malar J. 2010 Jun 2;9:149.
Economic analysis of childhood pneumonia in Northern Pakistan.
Hussain H, Waters H, Khan AJ, Omer SB, Halsey NA.
Health Policy Plan. 2008 Nov;23(6):438-42. Epub 2008 Aug 28.
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.
Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.
Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study.
Huy R, Wichmann O, Beatty M, Ngan C, Duong S, Margolis HS, Vong S.
BMC Public Health. 2009 May 27;9:155.
The economic cost to households of childhood malaria in Papua New Guinea: a focus on intra-country variation.
Sicuri E, Davy C, Marinelli M, Oa O, Ome M, Siba P, Conteh L, Mueller I.
Health Policy Plan. 2011 Jun 22. [Epub ahead of print]
The cost of treating paediatric malaria admissions and the potential impact of insecticide-treated mosquito nets on hospital expenditure.
Kirigia JM, Snow RW, Fox-Rushby J, Mills A.
Trop Med Int Health. 1998 Feb;3(2):145-50.
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J, Jones J, Takeda A, Davidson P, Price A.
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.
Variation in patient routine costliness in U.S. psychiatric facilities.
Cromwell J, Drozd EM, Gage B, Maier J, Richter E, Goldman HH.
J Ment Health Policy Econ. 2005 Mar;8(1):15-28.
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.
Health Technol Assess. 2001;5(32):1-195. Review.
[Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland].
Jahnz-Rózyk K.
Pol Merkur Lekarski. 2010 Jul;29(169):37-40. Polish.
Treatment in Kenyan rural health facilities: projected drug costs using the WHO-UNICEF integrated management of childhood illness (IMCI) guidelines.
Boulanger LL, Lee LA, Odhacha A.
Bull World Health Organ. 1999;77(10):852-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on